US › Healthcare

Encompass Health Corp (EHC)

US · Healthcare · Medical Care Facilities

$110.50-1.75%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$1.59B
Revenue YoY
+9.0%
Net profit
$194.5M
Profit YoY
+28.4%
EPS
$1.60
EPS estimate
$1.49
Net margin
12.3%

EPS came in at 1.60 against a street estimate of 1.49 — a beat of 7.4%.

Key statistics

Market cap
$11.16B
P/E
19.3
Forward P/E
18.6
P/B
4.37
Book value
$25.37
EPS (TTM)
$5.84
Dividend yield
0.67%
52-week high
$127.27
52-week low
$92.41
50-day MA
$105.88
200-day MA
$107.10
Beta
0.60

Analyst view

Analysts rate Encompass Health Corp a strong buy (12 buy, 0 hold, 0 sell out of 12) with an average price target of $140.50.

Shareholding

Insiders
1.07%
Institutions
101.61%

Largest institutional holders

FundStake
BlackRock Inc10.86%
Vanguard Group Inc10.21%
Vanguard Portfolio Management, LLC5.00%
T. Rowe Price Associates, Inc.4.64%
Vanguard Capital Management, LLC4.50%
Wellington Management Company LLP3.88%
Amvescap Plc.3.41%
T. Rowe Price Investment Management,Inc.3.25%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Encompass Health Corp — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.